Clinical trial
Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease
NCT00423228 · Debiopharm International SA, Industry · Completed
Key facts
| NCT number | NCT00423228 |
|---|---|
| Title | Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease |
| Official title | A Randomised, Double-blind, Double-dummy, Oral Donepezil Controlled Study on the Safety and Efficacy of Repeated Monthly Subcutaneous Injections of a Sustained-release Implant of ZT 1 in Patients With Moderate Alzheimer's Disease |
| Acronym | BRAINz |
| Lead sponsor | Debiopharm International SA, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Moderate Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | ZT-1, Donepezil |
| Enrollment | 228 |
| Start date | Feb 1, 2007 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Jan 18, 2007 |
| Last update posted | Jan 14, 2015 |
| Countries | Australia, Canada, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: